Pfizer

PFE

30.650
USD
0.115
(0.38%)
Market Closed
Volume
790,722
EPS
0
Div Yield
0
P/E
-63
Market Cap
163,994,155,152

Signals

sara abdelazim
1 year ago
buy
PFE@36.61
2023-08-24 14:20
Profit
-457.5
sara abdelazim
1 year ago
buy
PFE@35.38
2023-08-16 11:49
Profit
16.5

Related Instruments

ABBV
4.380
(2.36%)
189.700 USD
ABT
4.220
(3.98%)
110.150 USD
AZN
2.040
(2.58%)
81.200 USD
BMY
0.620
(1.30%)
48.180 USD
GILD
0.470
(0.62%)
76.510 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
MRNA
-25.020
(-20.99%)
94.160 USD
NVS
0.650
(0.58%)
112.100 USD
SNY
-0.090
(-0.17%)
51.700 USD

News

Title: Pfizer

Sector: Healthcare
Industry: Drug Manufacturers - General
Pfizer Inc. is a large research-based pharmaceutical and biomedical company. As an American multinational firm, it researches and develops medicines and vaccines for immunology, oncology, cardiology, endocrinology and neurology. The company was established in 1849 in New York by two German businessmen, Charles Pfizer and Charles F. Erhart. Pfizer Inc. is headquartered in New York City and has appeared in the top 50 companies on the Forbes Global 2000 list.